Top

Published in:

Open Access 01-12-2010 | Review

Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature

Authors: Wobbe Bouma, Theo J Klinkenberg, Iwan CC van der Horst, Inez J Wijdh-den Hamer, Michiel E Erasmus, Marc Bijl, Albert JH Suurmeijer, Felix Zijlstra, Massimo A Mariani

Published in: Journal of Cardiothoracic Surgery | Issue 1/2010

Abstract

Libman-Sacks endocarditis of the mitral valve was first described by Libman and Sacks in 1924. Currently, the sterile verrucous vegetative lesions seen in Libman-Sacks endocarditis are regarded as a cardiac manifestation of both systemic lupus erythematosus (SLE) and the antiphospholipid syndrome (APS). Although typically mild and asymptomatic, complications of Libman-Sacks endocarditis may include superimposed bacterial endocarditis, thromboembolic events, and severe valvular regurgitation and/or stenosis requiring surgery. In this study we report two cases of mitral valve repair and two cases of mitral valve replacement for mitral regurgitation (MR) caused by Libman-Sacks endocarditis. In addition, we provide a systematic review of the English literature on mitral valve surgery for MR caused by Libman-Sacks endocarditis. This report shows that mitral valve repair is feasible and effective in young patients with relatively stable SLE and/or APS and only localized mitral valve abnormalities caused by Libman-Sacks endocarditis. Both clinical and echocardiographic follow-up after repair show excellent mid- and long-term results.

Available only for authorised users

Libman E, Sacks B: A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med. 1924, 33: 701-37.CrossRef

Gross L: The cardiac lesions in Libman-Sacks disease with a consideration of its relationship to acute diffuse lupus erythematosus. Am J Pathol. 1940, 16: 375-407.PubMedPubMedCentral

D'Alton JG, Preston DN, Bormanis J, Green MS, Kraag GR: Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis. Stroke. 1985, 16: 512-4.CrossRefPubMed

Cervera R, Khamashta MA, Font J, Reyes PA, Vianna JL, López-Soto A, Amigo MC, Asherson RA, Azqueta M, Paré C, Vargas J, Romero A, Ingelmo M, Hughes GRV: High prevalence of significant heart valve lesions in patients with the "primary" antiphospholipid syndrome. Lupus. 1991, 1: 43-7. 10.1177/096120339100100108.CrossRefPubMed

Hojnik M, George J, Ziporen L, Shoenfeld Y: Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation. 1996, 93: 1579-87.CrossRefPubMed

Doherty NE, Siegel RJ: Cardiovascular manifestations of systemic lupus eryhematosus. Am Heart J. 1985, 110: 1257-65. 10.1016/0002-8703(85)90023-7.CrossRefPubMed

Ansari A, Larson PH, Bates HD: Cardiovascular manifestations of systemic lupus erythematosus: current perspective. Prog Cardiovasc Dis. 1985, 27: 421-34. 10.1016/0033-0620(85)90003-9.CrossRefPubMed

Moyssakis I, Tektonidou MG, Vasilliou VA, Samarkos M, Votteas V, Moutsopoulos HM: Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med. 2007, 120: 636-42. 10.1016/j.amjmed.2007.01.024.CrossRefPubMed

Roldan CA, Shively BK, Lau CC, Gurule FT, Smith EA, Crawford MH: Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol. 1992, 20: 1127-34.CrossRefPubMed

10.

Roldan CA, Shively BK, Crawford MH: An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med. 1996, 335: 1424-30. 10.1056/NEJM199611073351903.CrossRefPubMed

11.

Hughes GR, Harris NN, Gharavi AE: The anticardiolipin syndrome. J Rheumatol. 1986, 13: 486-9.PubMed

12.

Harris EN: A reassessment of the antiphospholipid syndrome. J Rheumatol. 1990, 17: 733-5.PubMed

13.

Levine JS, Branch DW, Rauch J: The antiphospholipid syndrome. N Engl J Med. 2002, 346: 752-63. 10.1056/NEJMra002974.CrossRefPubMed

14.

Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Artritis Rheum. 1999, 42: 1309-11. 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F.CrossRef

15.

Khamashta MA, Cervera R, Asherson RA, Font J, Gil A, Coltart DJ, Vázquez JJ, Paré C, Ingelmo M, Oliver J, Hughes GR: Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet. 1990, 335: 1541-4. 10.1016/0140-6736(90)91373-I.CrossRefPubMed

16.

Takayama T, Teramura M, Sakai H, Tamaki S, Okabayashi T, Kawashima T, Yamamoto T, Horie M, Suzuki T, Asai T: Perforated mitral valve aneurysm associated with Libman-Sacks endocarditis. Inter Med. 2008, 47: 1605-8. 10.2169/internalmedicine.47.1068.CrossRef

17.

Chartash EK, Lans DM, Paget SA, Qamar T, Lockshin MD: Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Med. 1989, 86: 407-12. 10.1016/0002-9343(89)90337-9.CrossRefPubMed

18.

Ford SE, Charrette EJ, Knight J, Pym J, Ford P: A possible role for antiphospholipid antibodies in acquired cardiac valve deformity. J Rheumatol. 1990, 17: 1499-503.PubMed

19.

Ziporen L, Goldberg I, Arad M, Hojnik M, Ordi-Ros J, Afek A, Blank M, Sandbank Y, Vilardell-Tarres M, de Torres I, Weinberger A, Asherson RA, Kopolovic Y, Shoenfeld Y: Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus. 1996, 5: 196-205. 10.1177/096120339600500306.CrossRefPubMed

20.

Gleason CB, Stoddard MF, Wagner SG, Longaker RA, Pierangeli S, Harris EN: A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus. Am Heart J. 1993, 125: 1123-9. 10.1016/0002-8703(93)90124-R.CrossRefPubMed

21.

Asherson RA, Cervera R: Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist. Circulation. 1991, 84: 920-3.CrossRefPubMed

22.

Asopa S, Patel A, Khan OA, Sharma R, Ohri SK: Non-bacterial thrombotic endocarditis. Eur J Cardiothorac Surg. 2007, 32: 696-701. 10.1016/j.ejcts.2007.07.029.CrossRefPubMed

23.

Mottram PM, Gelman JS: Mitral valve thrombus mimicking a primary tumor in the antiphospholipid syndrome. J Am Soc Echocardiogr. 2002, 15: 746-8. 10.1067/mje.2002.118914.CrossRefPubMed

24.

Taguchi S, Hashimoto K, Sakamoto Y, Okuyama H, Ishii S: A case of mitral valve plasty for Libman-Sacks endocarditis mimicking a cardiac tumor. J Thorac Cardiovasc Surg. 2006, 132: 1465-7. 10.1016/j.jtcvs.2006.07.034.CrossRefPubMed

25.

Appelbe AF, Olson D, Mixon R, Craver JM, Martin RP: Libman-Sacks endocarditis mimicking intracardiac tumor. Am J Cardiol. 1991, 68: 817-8. 10.1016/0002-9149(91)90666-9.CrossRefPubMed

26.

Lee JL, Naguwa SM, Cheema GS, Gershwin ME: Revisiting Libman-Sacks endocarditis: a historical review and update. Clin Rev Allergy Immunol. 2009, 36: 126-30. 10.1007/s12016-008-8113-y.CrossRefPubMed

27.

Lehman TJ, Palmeri ST, Hastings C, Klippel JH, Plotz PH: Bacterial endocarditis complicating systemic lupus erythematosus. J Rheumatol. 1983, 10: 655-8.PubMed

28.

Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, Bashore T, Corey GR: Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000, 30: 633-8. 10.1086/313753.CrossRefPubMed

29.

Ménard GE: Establishing the diagnosis of Libman-Sacks endocarditis in systemic lupus erythematosus. J Gen Intern Med. 2008, 23: 883-6. 10.1007/s11606-008-0627-8.CrossRefPubMedPubMedCentral

30.

Feigenbaum H, Armstrong WF, Ryan T: Feigenbaum's Echocardiography. 2005, Philadelphia: Lippincott Williams and Wilkins, 375-81.

31.

Klarich KW, Enriquez-Sarano M, Gura GM, Edwards WD, Tajik AJ, Seward JB: Papillary firboelastoma: echocardiographic characteristics for diagnosis and pathologic correlation. J Am Coll Cardiol. 1997, 30: 784-90. 10.1016/S0735-1097(97)00211-8.CrossRefPubMed

32.

Roldan CA, Qualls CR, Sopko KS, Sibbitt WL: Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: a randomized controlled study. J Rheumatol. 2008, 35: 224-9.PubMed

33.

Morin AM, Boyer AS, Nataf P, Gandjbakhch I: Mitral insufficiency caused by systemic lupus erythematosus requiring valve replacement: three case reports and a review of the literature. Thorac Cardiovasc Surg. 1996, 44: 313-6. 10.1055/s-2007-1012045.CrossRefPubMed

34.

Bulkey BH, Roberts WC: Systemic lupus erythematosus as a cause of severe mitral regurgitation. New problem in an old disease. Am J Cardiol. 1975, 35: 305-8. 10.1016/0002-9149(75)90018-1.CrossRefPubMed

35.

Hoffman R, Lethen H, Zunker U, Schöndube FA, Maurin N, Sieberth HG: Rapid appearance of severe mitral regurgitation under high-dosage corticosteroid therapy in a patient with systemic lupus erythematosus. Eur Heart J. 1994, 15: 138-9.PubMed

36.

Gonzalez-Juanatey C, Gonzalez-Gay MA: Libman-Sacks endocarditis and primary antiphospholipid syndrome. J Heart Valve Dis. 2005, 14: 700-2.PubMed

37.

Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K: ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J. 2008, 29: 2388-442. 10.1093/eurheartj/ehn309.CrossRefPubMed

38.

Yun KL, Miller DC: Mitral valve repair versus replacement. Cardiol Clin. 1991, 9: 315-27.PubMed

39.

Gillinov AM, Cosgrove DM: Current status of mitral valve repair. Am Heart Hosp J. 2003, 1: 47-54. 10.1111/j.1541-9215.2003.02082.x.CrossRefPubMed

40.

Kalangos A, Panos A, Sezerman O: Mitral valve repair in lupus valvulitis - report of a case and review of the literature. J Heart Valve Dis. 1995, 4: 202-7.PubMed

41.

Chauvaud SM, Kalangos A, Berrebi AJ, Gaer AR, Acar C, Carpentier AF: Systemic lupus erythematosus valvulitis: mitral valve replacement with a homograft. Ann Thorac Surg. 1995, 60: 1803-5. 10.1016/0003-4975(95)00625-7.CrossRefPubMed

42.

Hakim JP, Mehta A, Jain AC, Murray GF: Mitral valve replacement and repair. Report of 5 patients with systemic lupus erythematosus. Tex Heart Inst J. 2001, 28: 47-52.PubMedPubMedCentral

43.

Kato Y, Isobe F, Sasaki Y, Kodera K, Kumano H, Nagamachi K: Mitral insufficiency associated with primary antiphospholipid syndrome and chronic renal failure. Jpn J Thorac Cardiovasc Surg. 2001, 49: 171-4. 10.1007/BF02913596.CrossRefPubMed

44.

Schneider C, Bahlmann E, Antz M, Bauer R, Reimers J, Raut W, Busch C, Rathjen F, Moll R, Kuck KH: Images in cardiovascular medicine. Unusual manifestation of Libman-Sacks endocarditis in systemic lupus erythematosus. Circulation. 2003, 107: e202-4. 10.1161/01.CIR.0000063926.32375.D3.CrossRefPubMed

45.

Fernández-Dueñas J, López-Granados A, Mesa-Rubio D, Ariz-Cañete J, Gallo-Marín M, Concha-Ruiz M: Severe mitral regurgitation in Libman-Sacks endocarditis. Conservative surgery. Rev Esp Cardiol. 2005, 58: 1118-20. 10.1157/13078558.CrossRefPubMed

46.

Gordon RJ, Weilbaecher D, Davy SM, Safi HJ, Quiñones MA, DeFelice CA, Zoghbi WA: Valvulitis involving a bioprosthetic valve in a patient with systematic lupus erythematosus. J Am Soc Echocardiogr. 1996, 9: 104-7. 10.1016/S0894-7317(96)90112-1.CrossRefPubMed

47.

Da Silva AN, Ferreira LD, Monaco CG, Silva CE, Gil MA, Peixoto LB, Ortiz J: Intracardiac thrombus and mitral prosthesis dysfunction in systemic lupus erythematosus. A case report. Rev Port Cardiol. 2003, 22: 213-9.PubMed

48.

Myerowitz PD, Michaelis LL, McIntosh CL: Mitral valve replacement for mitral regurgitation due to Libman-Sacks endocarditis. Report of a case. J Thorac Cardiovasc Surg. 1974, 67: 869-74.PubMed

49.

Murray FT, Fuleihan DS, Cornwall CS, Pinals RS: Acute mitral regurgitation from ruptured chordae tendineae in systemic lupus erythematosus. J Rheumatol. 1975, 2: 454-9.PubMed

50.

Paget SA, Bulkley BH, Grauer LE, Seningen R: Mitral valve disease of systemic lupus erythematosus. A cause of severe congestive heart failure reversed by valve replacement. Am J Med. 1975, 59: 134-9. 10.1016/0002-9343(75)90331-9.CrossRefPubMed

51.

Kinney EL, Wynn J, Ward S, Babb JD, Wine-Shaffer C, Zelis R: Ruptured chordae tendineae. Its association with systemic lupus erythematosus. Arch Pathol Lab Med. 1980, 104: 595-6.PubMed

52.

Rawsthorne L, Ptacin MJ, Choi H, Olinger GN, Bamrah VS: Lupus valvulitis necessitating double valve replacement. Arthritis Rheum. 1981, 24: 561-4. 10.1002/art.1780240319.CrossRefPubMed

53.

Brennan FJ, Ford SE, Ford PM, Morrin PA, Burggraf GW, Salerno TA: Mitral regurgitation due to lupus endocarditis treated with valve replacement. Can Med Assoc J. 1983, 129: 584-7.PubMedPubMedCentral

54.

Rozman B, Radovanovic N, Zorc M, Vraspir-Porenta O, Cijan A, Zemva A: Mitral valve replacement for lupus valvulitis. Z Rheumatol. 1986, 45: 322-4.PubMed

55.

Moynihan T, Hansen R, Troup P, Olinger G: Simultaneous aortic and mitral valve replacement for lupus endocarditis: report of a case and review of the literature. J Thorac Cardiovasc Surg. 1988, 95: 142-5.PubMed

56.

Straaton KV, Chatham WW, Reveille JD, Koopman WJ, Smith SH: Clinically significant valvular heart disease in systemic lupus erythematosus. Am J Med. 1988, 85: 645-50. 10.1016/S0002-9343(88)80236-5.CrossRefPubMed

57.

Ferraris VA, Hawksley VC, Rabinowitz M, Coyne CM, Sullivan TJ, Sprague MS: Double valve replacement for lupus valvulitis: report of a case and review of the literature. Tex Heart Inst J. 1990, 17: 56-60.PubMedPubMedCentral

58.

Alvarez-Blanco A, Egurbide-Arberas MV, Aguirre-Errasti C: Severe valvular heart disease in a patient with primary antiphospholipid syndrome. Lupus. 1994, 3: 433-4.PubMed

59.

Shahian DM, Labib SB, Schneebaum AB: Etiology and management of chronic valve disease in antiphospholipid antibody syndrome and systemic lupus erythematosus. J Card Surg. 1995, 10: 133-9.CrossRefPubMed

60.

East CJ, Clements F, Mathew J, Slaughter TF: Antiphospholipid syndrome and cardiac surgery: management of anticoagulation in two patients. Anesth Analg. 2000, 90: 1098-101. 10.1097/00000539-200005000-00017.CrossRefPubMed

61.

Georghiou GP, Shapira Y, Drozd T, Erez E, Raanani E, Vidne BA, Sahar G: Double-valve Libman-Sacks endocarditis: an entity that demands special consideration. J Heart Valve Dis. 2003, 12: 797-801.PubMed

62.

Bordin G, Boldorini R, Meroni PL: The two hit hypothesis in the antiphospholipid syndrome: acute ischaemic heart involvement after valvular replacement despite anticoagulation in a patient with secondary APS. Lupus. 2003, 12: 851-3. 10.1191/0961203303lu445cr.CrossRefPubMed

63.

Berkun Y, Elami A, Meir K, Mevorach D, Naparstek Y: Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery. J Thorac Cardiovasc Surg. 2004, 127: 414-20. 10.1016/j.jtcvs.2003.07.016.CrossRefPubMed

64.

Einav E, Gitig A, Marinescu LM, Tanaka KE, Spevack DM: Valvulitis requiring triple valve surgery as an initial presentation of systemic lupus erythematosus. J Am Soc Echocardiogr. 2007, 20: e1-3.CrossRef

Title: Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature
Authors: Wobbe Bouma
Theo J Klinkenberg
Iwan CC van der Horst
Inez J Wijdh-den Hamer
Michiel E Erasmus
Marc Bijl
Albert JH Suurmeijer
Felix Zijlstra
Massimo A Mariani
Publication date: 01-12-2010
Publisher: BioMed Central
Published in: Journal of Cardiothoracic Surgery / Issue 1/2010
Electronic ISSN: 1749-8090
DOI: https://doi.org/10.1186/1749-8090-5-13

At a glance: The STEP trials

Springer Medicine

Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2010

Thoracoscopic resection of a paraaortic bronchogenic cyst

Does pleural fluid appearance really matter? The relationship between fluid appearance and cytology, cell counts, and chemical laboratory measurements in pleural effusions of patients with cancer

Bilateral heterochronic spontaneous hemothorax caused by pulmonary arteriovenous malformation in a gravid: A case report

Spontaneous chylous cardiac tamponade: a case report

Surgical resection of a renal cell carcinoma involving the inferior vena cava: the role of the cardiothoracic surgeon

Long-term mortality prediction after operations for type A ascending aortic dissection